![Peter Selin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Selin formerly worked at Vivesto AB, as Chief Business Officer, Inceptua SA, as Vice President-Pharma Business Operations, and Novakand Pharma AB, as Executive Vice President-Corporate Development from 2022 to 2023.
Mr. Selin received his undergraduate degree from the University of Uppsala.
| Unternehmen | Position | Ende |
|---|---|---|
| VIVESTO AB | Corporate Officer/Principal | - |
| KANCERA AB | Vorstandsvorsitzender | - |
Inceptua SA
 Inceptua SA Medical/Nursing ServicesHealth Services Operates pharmaceutical company that provides clinical trial and medicines access services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Kancera AB
 Kancera AB Pharmaceuticals: MajorHealth Technology Develops drugs against inflammation and cancer | Health Technology |
Inceptua SA
Inceptua SA Medical/Nursing ServicesHealth Services Operates pharmaceutical company that provides clinical trial and medicines access services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
